Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
5.438
Zitationen
47
Autoren
2017
Jahr
Abstract
BACKGROUND: The effect of endovascular thrombectomy that is performed more than 6 hours after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is disproportionately severe relative to the infarct volume may benefit from late thrombectomy. METHODS: We enrolled patients with occlusion of the intracranial internal carotid artery or proximal middle cerebral artery who had last been known to be well 6 to 24 hours earlier and who had a mismatch between the severity of the clinical deficit and the infarct volume, with mismatch criteria defined according to age (<80 years or ≥80 years). Patients were randomly assigned to thrombectomy plus standard care (the thrombectomy group) or to standard care alone (the control group). The coprimary end points were the mean score for disability on the utility-weighted modified Rankin scale (which ranges from 0 [death] to 10 [no symptoms or disability]) and the rate of functional independence (a score of 0, 1, or 2 on the modified Rankin scale, which ranges from 0 to 6, with higher scores indicating more severe disability) at 90 days. RESULTS: A total of 206 patients were enrolled; 107 were assigned to the thrombectomy group and 99 to the control group. At 31 months, enrollment in the trial was stopped because of the results of a prespecified interim analysis. The mean score on the utility-weighted modified Rankin scale at 90 days was 5.5 in the thrombectomy group as compared with 3.4 in the control group (adjusted difference [Bayesian analysis], 2.0 points; 95% credible interval, 1.1 to 3.0; posterior probability of superiority, >0.999), and the rate of functional independence at 90 days was 49% in the thrombectomy group as compared with 13% in the control group (adjusted difference, 33 percentage points; 95% credible interval, 24 to 44; posterior probability of superiority, >0.999). The rate of symptomatic intracranial hemorrhage did not differ significantly between the two groups (6% in the thrombectomy group and 3% in the control group, P=0.50), nor did 90-day mortality (19% and 18%, respectively; P=1.00). CONCLUSIONS: Among patients with acute stroke who had last been known to be well 6 to 24 hours earlier and who had a mismatch between clinical deficit and infarct, outcomes for disability at 90 days were better with thrombectomy plus standard care than with standard care alone. (Funded by Stryker Neurovascular; DAWN ClinicalTrials.gov number, NCT02142283 .).
Ähnliche Arbeiten
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
1993 · 12.175 Zit.
Correspondence - Tranexamic acid for traumatic brain injury
2005 · 11.723 Zit.
Tissue Plasminogen Activator for Acute Ischemic Stroke
1995 · 11.639 Zit.
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 · 11.554 Zit.
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 · 10.200 Zit.
Autoren
- Raul G. Nogueira
- Ashutosh P. Jadhav
- Diogo C Haussen
- Alain Bonafé
- Ronald F. Budzik
- Parita Bhuva
- Dileep R. Yavagal
- Marc Ribó
- Christophe Cognard
- Ricardó A. Hanel
- Cathy Sila
- Ameer E Hassan
- Monica A. Millan
- Elad I. Levy
- Peter Mitchell
- Michael Chen
- Joey English
- Qaisar A. Shah
- Frank L. Silver
- Vítor Mendes Pereira
- Brijesh Mehta
- Blaise Baxter
- Michael Abraham
- Pedro Cardona
- Erol Veznedaroglu
- Frank R Hellinger
- Lei Feng
- Jawad F. Kirmani
- Demetrius K. Lopes
- Brian T. Jankowitz
- Michael Frankel
- Vincent Costalat
- Nirav Vora
- Albert J. Yoo
- Amer Malik
- Anthony J. Furlan
- Marta Rubiera
- Amin Aghaebrahim
- Jean‐Marc Olivot
- Wondwossen Tekle
- Ryan Shields
- Todd Graves
- Roger Lewis
- Wade S. Smith
- David S. Liebeskind
- Jeffrey L. Saver
- Tudor G. Jovin
Institutionen
- Emory University(US)
- Stroke Association(GB)
- Hôpital Gui de Chauliac(FR)
- Riverside Methodist Hospital(US)
- OhioHealth(US)
- Jackson Memorial Hospital(US)
- University of Miami(US)
- Vall d'Hebron Hospital Universitari(ES)
- Université de Toulouse(FR)
- Baptist Medical Center Jacksonville(US)
- University Hospitals of Cleveland(US)
- Valley Baptist Medical Center(US)
- Hospital Universitari Germans Trias i Pujol(ES)
- Universitat Autònoma de Barcelona(ES)
- University at Buffalo, State University of New York(US)
- Rush University Medical Center(US)
- The Royal Melbourne Hospital(AU)
- California Pacific Medical Center(US)
- Abington Memorial Hospital(US)
- University of Pittsburgh Medical Center(US)
- Neurology, Inc(US)
- Memorial Regional Hospital(US)
- Erlanger Health System(US)
- Health Net(US)
- University of Kansas Medical Center(US)
- Bellvitge University Hospital(ES)
- Capital Health(US)
- University of Toronto(CA)
- University Health Network(CA)
- Capital District Health Authority(CA)
- Toronto Western Hospital(CA)
- AdventHealth Orlando(US)
- Kaiser Permanente San Francisco Medical Center(US)
- Stryker (United States)(US)
- Berry & Associates (United States)(US)
- UCLA Medical Center(US)
- Harbor–UCLA Medical Center(US)
- University of California, San Francisco(US)